WEST PHARMACEUTICAL SERVICES, INC. (WST) Free cash flow 2016–2025
WEST PHARMACEUTICAL SERVICES, INC. (WST) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
$468.9MFY2025 · since FY2016: $49.2M → $468.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $468.9M | +69.6% |
| FY2024 | $276.4M | -33.3% |
| FY2023 | $414.5M | -5.7% |
| FY2022 | $439.4M | +32.9% |
| FY2021 | $330.6M | +10.9% |
| FY2020 | $298.1M | +23.8% |
| FY2019 | $240.8M | +30.9% |
| FY2018 | $183.9M | +38.8% |
| FY2017 | $132.5M | +169.3% |
| FY2016 | $49.2M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice